...
首页> 外文期刊>Nature >Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans
【24h】

Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans

机译:秀丽隐杆线虫的多药转运蛋白P-糖蛋白的晶体结构

获取原文
获取原文并翻译 | 示例

摘要

P-glycoprotein (P-gp) is an ATP-binding cassette transporter that confers multidrug resistance in cancer cells~(1,2) It also affects the absorption, distribution and clearance of cancer-unrelated drugs and xenobiotics. For these reasons, the structure and function of P-gp have been studied extensively for decades~3. Here we present biochemical characterization of P-gp from Caenorhabditis elegans and its crystal structure at a resolution of 3.4 angstroms. We find that the apparent affinities of P-gp for anticancer drugs actinomycin D and paclitaxel are approximately 4,000 and 100 times higher, respectively, in the membrane bilayer than in detergent. This affinity enhancement highlights the importance of membrane partitioning when a drug accesses the transporter in the membrane~4. Furthermore, the transporter in the crystal structure opens its drug pathway at the level of the membrane's inner leaflet. In the helices flanking the opening to the membrane, we observe extended loops that may mediate drug binding, function as hinges to gate the pathway or both. We also find that the interface between the transmem-brane and nudeotide-binding domains, which couples ATP hydrolysis to transport, contains a ball-and-socket joint and salt bridges similar to the ATP-binding cassette importers~5, suggesting that ATP-binding cassette exporters and importers may use similar mechanisms to achieve alternating access for transport. Finally, a model of human P-gp derived from the structure of C. elegans P-gp not only is compatible with decades of biochemical analysis~(6-12), but also helps to explain perplexing functional data regarding the Phe335Ala mutant~(13,14). These results increase our understanding of the structure and function of this important molecule.%ABC(ATP—binding cassette)转运蛋白“P-糖蛋白”在癌细胞中产生多药物抗性。本文作者在生化上和结构上对来自线虫的“P-糖蛋白”进行了定性,并用该信息生成一个人“P-糖蛋白”的同源模型。他们的数据反映了“P-糖蛋白”是怎样利用来自ATP水解的能量将亲脂性分子从细胞膜的内叶驱赶出去的。
机译:P-糖蛋白(P-gp)是一种ATP结合盒转运蛋白,可赋予癌细胞多药耐药性[1,2],它还影响与癌症无关的药物和异种生物的吸收,分布和清除。由于这些原因,对P-gp的结构和功能的研究已有数十年之久。在这里,我们介绍了秀丽隐杆线虫的P-gp的生化特征及其晶体结构,分辨率为3.4埃。我们发现,P-gp对抗癌药物放线菌素D和紫杉醇的表观亲和力在膜双层中分别比在洗涤剂中高约4,000和100倍。当药物接近膜中的转运蛋白时,这种亲和力增强突出了膜分配的重要性。此外,晶体结构中的转运蛋白在膜内部小叶的水平上打开了它的药物通道。在膜开口侧翼的螺旋中,我们观察到延长的环可能介导药物结合,起铰接作用以控制通道或两者兼有。我们还发现,跨膜和裸肽结合结构域之间的界面(耦合ATP水解以进行运输)包含一个类似于ATP结合盒式进口商的球窝接头和盐桥〜5,这表明ATP-装订盒出口商和进口商可以使用类似的机制来实现交替运输。最后,由秀丽隐杆线虫P-gp结构衍生的人P-gp模型不仅与数十年的生化分析兼容(6-12),而且有助于解释关于Phe335Ala突变体的令人困惑的功能数据-( 13,14)。这些结果加深了我们对该重要分子的结构和功能的了解。%ABC(ATP结合盒)转运蛋白“ P-糖蛋白”在纳米纤维中产生多药物抗性。本文作者在生化上和结构上对来自线虫的“ P-糖蛋白”进行了定性,并用该信息生成一个人“ P-糖蛋白”的同源模型。他们的数据反映了“ P-糖蛋白”是如何利用来自ATP分解的能量将亲脂性分子从细胞膜的内叶驱赶出去的。

著录项

  • 来源
    《Nature 》 |2012年第7421期| p.566-569A5| 共5页
  • 作者单位

    Department of Biological Sciences, Purdue University, Indiana 47907, USA;

    Howard Hughes Medical Institute, West Lafayette, Indiana 47907, USA;

    Howard Hughes Medical Institute, West Lafayette, Indiana 47907, USA;

    Department of Biological Sciences, Purdue University, Indiana 47907, USA Howard Hughes Medical Institute, West Lafayette, Indiana 47907, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号